Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

[Constellations of findings and derived treatment interventions in telemedical monitoring of patients with heart failure, cardiac arrhythmia or increased risk for sudden cardiac death : Recommendations of the working group 33 telemonitoring of the German Cardiac Society].

Helms TM, Stockburger M, Schwab JO, Hindricks G, Köhler F, Leonhardt V, Müller A, Rybak K, Sack S, Zugck C, Zippel-Schultz B, Perings CA; Arbeitsgruppe 33/Telemonitoring in der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung e. V. (DGK) und assoziierte Mitglieder.

Herzschrittmacherther Elektrophysiol. 2019 Sep;30(3):298-305. doi: 10.1007/s00399-019-0632-0. Review. German.

PMID:
31410560
2.

[Position paper telemonitoring : From the Nucleus Members of the AG33 Telemonitoring of the DGK and associated members].

Helms TM, Stockburger M, Köhler F, Leonhardt V, Müller A, Rybak K, Sack S, Schwab JO, Zugck C, Zippel-Schultz B, Perings CA; Arbeitsgruppe 33/Telemonitoring in der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung e. V. (DGK) und assoziierte Mitglieder.

Herzschrittmacherther Elektrophysiol. 2019 Sep;30(3):287-297. doi: 10.1007/s00399-019-0630-2. Review. German.

PMID:
31278607
3.

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, Winkler S, Vettorazzi E, Bruch L, Oeff M, Zugck C, Doerr G, Naegele H, Störk S, Butter C, Sechtem U, Angermann C, Gola G, Prondzinsky R, Edelmann F, Spethmann S, Schellong SM, Schulze PC, Bauersachs J, Wellge B, Schoebel C, Tajsic M, Dreger H, Anker SD, Stangl K.

Lancet. 2018 Sep 22;392(10152):1047-1057. doi: 10.1016/S0140-6736(18)31880-4. Epub 2018 Aug 25.

PMID:
30153985
4.

Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations.

Zugck C, Störk S, Stöckl G; RELIf-CHF study investigators.

Int J Cardiol. 2017 Aug 1;240:258-264. doi: 10.1016/j.ijcard.2017.03.131. Epub 2017 Apr 11.

PMID:
28408104
5.

[Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP].

Luchner A, von Haehling S, Holubarsch C, Keller T, Knebel F, Zugck C, Laufs U.

Dtsch Med Wochenschr. 2017 Mar;142(5):346-355. doi: 10.1055/s-0042-117368. Epub 2017 Mar 10. Review. German.

PMID:
28282683
6.

Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index.

Uszko-Lencer NHMK, Frankenstein L, Spruit MA, Maeder MT, Gutmann M, Muzzarelli S, Osswald S, Pfisterer ME, Zugck C, Brunner-La Rocca HP; TIME-CHF Investigators.

Int J Cardiol. 2017 Jan 15;227:901-907. doi: 10.1016/j.ijcard.2016.11.122. Epub 2016 Nov 9.

PMID:
27915084
7.

Periodontitis in Chronic Heart Failure.

Fröhlich H, Herrmann K, Franke J, Karimi A, Täger T, Cebola R, Katus HA, Zugck C, Frankenstein L.

Tex Heart Inst J. 2016 Aug 1;43(4):297-304. doi: 10.14503/THIJ-15-5200. eCollection 2016 Aug.

8.

Long-term outcome of patients with and without super-response to CRT-D.

Franke J, Keppler J, Abadei AK, Bajrovic A, Meme L, Zugck C, Raake PW, Zitron E, Katus HA, Frankenstein L.

Clin Res Cardiol. 2016 Apr;105(4):341-8. doi: 10.1007/s00392-015-0926-0. Epub 2015 Oct 23.

PMID:
26497005
9.

[The Wearable Cardioverter-Defibrillator (WCD)].

Helms TM, Müller A, Schwab JO, Bänsch D, Karle C, Klingenheben T, Zugck C, Perings C.

Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):129-33. doi: 10.1007/s00399-015-0365-7. Epub 2015 May 5. German.

PMID:
25939989
10.

[Is heart rate adequately controlled in chronic systolic heart failure patients in Germany? results from a nationwide survey (INDICATE)].

Zugck C, Martinka P, Stöckl G, Tschöpe C, Störk S.

Dtsch Med Wochenschr. 2015 Mar;140(5):e48-55. doi: 10.1055/s-0041-100608. Epub 2015 Mar 3. German.

PMID:
25734683
11.

Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure.

Franke J, Zugck C, Hochadel M, Hack A, Frankenstein L, Zhao JD, Ehlermann P, Nelles M, Zeymer U, Winkler R, Zahn R, Katus HA, Senges J.

Int J Cardiol Heart Vasc. 2015 Feb 26;7:61-68. doi: 10.1016/j.ijcha.2015.01.015. eCollection 2015 Jun 1.

12.

Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score.

Franke J, Lindmark A, Hochadel M, Zugck C, Koerner E, Keppler J, Ehlermann P, Winkler R, Zahn R, Katus HA, Senges J, Frankenstein L.

Clin Res Cardiol. 2015 Apr;104(4):334-41. doi: 10.1007/s00392-014-0786-z. Epub 2014 Nov 6.

PMID:
25373384
13.

Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.

Zugck C, Martinka P, Stöckl G.

Adv Ther. 2014 Sep;31(9):961-74. doi: 10.1007/s12325-014-0147-3. Epub 2014 Aug 27.

14.

Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.

von Scheidt W, Zugck C, Pauschinger M, Hambrecht R, Bruder O, Hartmann A, Rauchhaus M, Zahn R, Brachmann J, Tebbe U, Neumann T, Strasser RH, Böhm M, Störk S, Hochadel M, Heidemann P, Senges J.

Clin Res Cardiol. 2014 Dec;103(12):1006-14. doi: 10.1007/s00392-014-0743-x. Epub 2014 Jul 23.

PMID:
25052361
15.

[Differentiated antiplatelet therapy for acute coronary syndromes].

Schäfer A, Arntz HR, Boudriot E, Garlichs C, Hoffmann S, Ince H, Klingenheben T, Weil J, Zugck C, Helms TM, Silber S.

Dtsch Med Wochenschr. 2014 Jan;139(4):152-8. doi: 10.1055/s-0033-1359911. Epub 2014 Jan 15. Review. German.

PMID:
24430955
16.

Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage.

Horstmann S, Zugck C, Krumsdorf U, Rizos T, Rauch G, Geis N, Hardt S, Veltkamp R.

Neurology. 2014 Jan 14;82(2):135-8. doi: 10.1212/WNL.0000000000000022. Epub 2013 Dec 6.

17.

Homoarginine--an independent marker of mortality in heart failure.

Atzler D, Rosenberg M, Anderssohn M, Choe CU, Lutz M, Zugck C, Böger RH, Frey N, Schwedhelm E.

Int J Cardiol. 2013 Oct 12;168(5):4907-9. doi: 10.1016/j.ijcard.2013.07.099. Epub 2013 Jul 24. No abstract available.

PMID:
23890923
18.

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.

Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA.

Eur Heart J. 2014 Apr;35(16):1069-77. doi: 10.1093/eurheartj/eht251. Epub 2013 Jul 12.

PMID:
23853074
19.

Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy.

Frankenstein L, Hees H, Taeger T, Froehlich H, Dösch A, Cebola R, Zugck C, Katus HA.

Clin Res Cardiol. 2013 Oct;102(10):771-80. doi: 10.1007/s00392-013-0589-7. Epub 2013 Jun 26.

PMID:
23800786
20.

Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study.

Frankenstein L, Katus HA, Grundtvig M, Hole T, de Blois J, Schellberg D, Atar D, Zugck C, Agewall S; Norwegian Heart Failure Registry steering committee.

Eur J Clin Pharmacol. 2013 Oct;69(10):1747-55. doi: 10.1007/s00228-013-1512-x. Epub 2013 Jun 7.

PMID:
23743778
21.
22.

Immunosuppression with tacrolimus early after orthotopic heart transplantation: a comparison of prograf and advagraf.

Ghodsizad A, Koch A, Ungerer MN, Bordel V, Zugck C, Ehlermann P, Doesch A, Karck M, Ruhparwar A.

Heart Surg Forum. 2012 Dec;15(6):E307-9. doi: 10.1532/HSF98.20111145.

PMID:
23262045
23.

The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.

Anderssohn M, Rosenberg M, Schwedhelm E, Zugck C, Lutz M, Lüneburg N, Frey N, Böger RH.

J Card Fail. 2012 Dec;18(12):904-11. doi: 10.1016/j.cardfail.2012.10.011. Epub 2012 Nov 2.

PMID:
23207078
24.

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.

Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA.

Drug Des Devel Ther. 2012;6:289-95. doi: 10.2147/DDDT.S36578. Epub 2012 Oct 12.

25.

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.

Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, Schellberg D, Zugck C, Galuschky C, Giannitsis E, Hegenbart U, Ho AD, Katus HA, Schonland SO, Hardt SE.

J Am Coll Cardiol. 2012 Sep 18;60(12):1067-76. doi: 10.1016/j.jacc.2012.04.043. Epub 2012 Aug 8.

26.

Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptide.

Jørgensen B, Bertsch T, Bröker HJ, Schäfer M, Chapelle JP, Gadisseur R, Cowie MR, Dikkeschei B, Gurr E, Hayen W, Hafner G, Stiegler Y, Schönherr HR, Strasser RH, Weidtmann B, Folkerts H, Zugck C, Hofmann K, Zerback R.

Clin Lab. 2012;58(5-6):515-25.

PMID:
22783583
27.

Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?

Franke J, Wolter JS, Meme L, Keppler J, Tschierschke R, Katus HA, Zugck C.

Clin Res Cardiol. 2013 Jan;102(1):23-31. doi: 10.1007/s00392-012-0489-2. Epub 2012 Jul 4.

PMID:
22760479
28.

Incidence rates and predictors of major and minor depression in patients with heart failure.

Lossnitzer N, Herzog W, Störk S, Wild B, Müller-Tasch T, Lehmkuhl E, Zugck C, Regitz-Zagrosek V, Pankuweit S, Maisch B, Ertl G, Gelbrich G, Angermann CE; Competence Network Heart Failure.

Int J Cardiol. 2013 Jul 31;167(2):502-7. doi: 10.1016/j.ijcard.2012.01.062. Epub 2012 Feb 16.

PMID:
22341693
29.

Quantitative analysis of left ventricular dyssynchrony using cardiac computed tomography versus three-dimensional echocardiography.

Buss SJ, Schulz F, Wolf D, Hosch W, Galuschky C, Schummers G, Giannitsis E, Kauczor HU, Zugck C, Becker R, Hardt SE, Katus HA, Korosoglou G.

Eur Radiol. 2012 Jun;22(6):1303-9. doi: 10.1007/s00330-011-2375-0. Epub 2012 Jan 22.

PMID:
22270144
30.

HMGB1 is an independent predictor of death and heart transplantation in heart failure.

Volz HC, Laohachewin D, Schellberg D, Wienbrandt AR, Nelles M, Zugck C, Kaya Z, Katus HA, Andrassy M.

Clin Res Cardiol. 2012 Jun;101(6):427-35. doi: 10.1007/s00392-011-0409-x. Epub 2012 Jan 10.

PMID:
22231645
31.

Recompensation of heart and kidney function after treatment with peritoneal dialysis in a case of congestive heart failure.

Kihm LP, Hankel V, Zugck C, Remppis A, Schwenger V.

Case Rep Med. 2011;2011:197816. doi: 10.1155/2011/197816. Epub 2011 Nov 17.

32.

Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure.

Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S.

Clin Res Cardiol. 2012 Apr;101(4):263-72. doi: 10.1007/s00392-011-0388-y. Epub 2011 Dec 3.

PMID:
22139085
33.

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis.

Franke J, Schmahl D, Lehrke S, Pribe R, Bekeredjian R, Doesch AO, Ehlermann P, Schnabel P, Katus HA, Zugck C.

Case Rep Med. 2011;2011:203690. doi: 10.1155/2011/203690. Epub 2011 Sep 27.

34.

[The value of telemedicine in 2011 : standard care in heart failure therapy?].

Zugck C, Cebola R, Taeger T, Franke J.

Herz. 2011 Oct;36(7):608-13. doi: 10.1007/s00059-011-3511-y. Review. German.

PMID:
21912909
35.

Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes: comparison to clinical parameters and conventional wall motion readings.

Korosoglou G, Gitsioudis G, Voss A, Lehrke S, Riedle N, Buss SJ, Zugck C, Giannitsis E, Osman NF, Katus HA.

J Am Coll Cardiol. 2011 Sep 6;58(11):1140-9. doi: 10.1016/j.jacc.2011.03.063.

36.

A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting.

Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J.

Clin Res Cardiol. 2012 Jan;101(1):1-10. doi: 10.1007/s00392-011-0348-6. Epub 2011 Jul 27.

PMID:
21792560
37.

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

Franke J, Frankenstein L, Schellberg D, Bajrovic A, Wolter JS, Ehlermann P, Doesch AO, Nelles M, Katus HA, Zugck C.

Clin Res Cardiol. 2011 Dec;100(12):1059-67. doi: 10.1007/s00392-011-0340-1. Epub 2011 Jul 16.

PMID:
21779816
38.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C.

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22. Review. German. No abstract available.

PMID:
21432747
39.

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction.

Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann CE, Düngen HD, Scheffold T, Zugck C, Maisch B, Regitz-Zagrosek V, Hasenfuss G, Pieske BM, Wachter R.

Clin Res Cardiol. 2011 Sep;100(9):755-64. doi: 10.1007/s00392-011-0305-4. Epub 2011 Mar 17.

40.

Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy.

Frankenstein L, Remppis A, Giannitis E, Frankenstein J, Hess G, Zdunek D, Doesch A, Zugck C, Katus HA.

Clin Res Cardiol. 2011 Aug;100(8):633-40. doi: 10.1007/s00392-011-0285-4. Epub 2011 Feb 17.

PMID:
21327843
41.

Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil.

Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Ehlermann P, Zugck C, Katus HA.

Transplant Proc. 2010 Dec;42(10):4243-6. doi: 10.1016/j.transproceed.2010.09.047.

PMID:
21168674
42.

Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.

Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Dengler TJ, Ehlermann P, Zugck C, De Geest S, Katus HA.

Transplant Proc. 2010 Dec;42(10):4238-42. doi: 10.1016/j.transproceed.2010.09.074.

PMID:
21168673
43.

Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy.

Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H, Pribe R, Ehlermann P, Zugck C, Korosoglou G, Giannitsis E, Katus HA.

Heart. 2011 May;97(9):727-32. doi: 10.1136/hrt.2010.205542. Epub 2010 Nov 20.

PMID:
21097819
44.

Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.

Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA.

Basic Res Cardiol. 2011 Jan;106(1):25-35. doi: 10.1007/s00395-010-0126-z. Epub 2010 Oct 20.

PMID:
20957484
45.

Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion.

Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S, Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA.

J Am Coll Cardiol. 2010 Oct 5;56(15):1225-34. doi: 10.1016/j.jacc.2010.06.020.

46.

Early assessment of infarct size and prediction of functional recovery by quantitative myocardial blush grade in patients with acute coronary syndromes treated according to current guidelines.

Riedle N, Dickhaus H, Erbacher M, Steen H, Andrassy M, Lossnitzer D, Hardt S, Rottbauer W, Zugck C, Giannitsis E, Katus HA, Korosoglou G.

Catheter Cardiovasc Interv. 2010 Oct 1;76(4):502-10. doi: 10.1002/ccd.22540.

PMID:
20882653
47.

Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy.

Doesch AO, Mueller S, Konstandin M, Celik S, Kristen A, Frankenstein L, Goeser S, Kaya Z, Zugck C, Dengler TJ, Katus HA.

J Clin Apher. 2010;25(6):315-22. doi: 10.1002/jca.20263. Epub 2010 Sep 7.

PMID:
20824621
48.

Telemedical support in patients with chronic heart failure: experience from different projects in Germany.

Müller A, Schweizer J, Helms TM, Oeff M, Sprenger C, Zugck C.

Int J Telemed Appl. 2010;2010. pii: 181806. doi: 10.1155/2010/181806. Epub 2010 Aug 12.

49.

[Depression, social support and compliance in patients with chronic heart failure].

Reutlinger J, Müller-Tasch T, Schellberg D, Frankenstein L, Zugck C, Herzog W, Lossnitzer N.

Psychother Psychosom Med Psychol. 2010 Sep-Oct;60(9-10):380-4. doi: 10.1055/s-0030-1254146. Epub 2010 Aug 4. German.

PMID:
20687012
50.

Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma.

Schmitt L, Wiebel M, Frese F, Dehnert C, Zugck C, Bärtsch P, Mairbäurl H.

Eur Respir J. 2011 Feb;37(2):342-8. doi: 10.1183/09031936.00197309. Epub 2010 Jun 4.

Supplemental Content

Support Center